Upgrade to SI Premium - Free Trial

NeoGenomics (NEO)

17.04 +0.42 (2.53%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/28/26)

Latest Headlines

NeoGenomics expands digital pathology deal with Indica Labs October 15, 2026 7:06 AM - StreetInsider NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology October 15, 2026 7:05 AM - BizWire NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026 October 14, 2026 7:05 AM - BizWire Piper Sandler: 'Neogenomics (NEO) Is Winning the Community' October 7, 2026 9:14 AM - StreetInsider Neogenomics (NEO) PT Raised to $20 at StoneX October 6, 2026 8:09 AM - StreetInsider Neogenomics (NEO) PT Raised to $22 at Needham October 6, 2026 7:11 AM - StreetInsider BTIG Upgrades Neogenomics (NEO) to Buy October 6, 2026 5:54 AM - StreetInsider Form 4 NEOGENOMICS INC For: Oct 01 Filed by: Stone Warren October 5, 2026 4:29 PM - SEC Filing Form 8-K NEOGENOMICS INC For: Oct 05 October 5, 2026 4:08 PM - SEC Filing NeoGenomics names Warren Stone as CEO, effective January 2027 October 5, 2026 4:06 PM - StreetInsider NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan October 5, 2026 4:05 PM - BizWire Gentherm completes acquisition of Modine's Performance Technologies unit October 1, 2026 4:36 PM - StreetInsider Gentherm Completes Combination with Modine’s Performance Technologies Business October 1, 2026 4:36 PM - Globe NewsWire Anortech Receives US$1.0 Million Cash and Shares from Sarfartoq Ree Project Transaction September 3, 2026 9:00 AM - Globe NewsWire Greenland Mines closes Sarfartoq rare earth acquisition in Greenland September 2, 2026 9:00 AM - StreetInsider Greenland Mines Completes Acquisition of World-Class Rare Earth Nd-Pr Magnet and Defense Mine Asset Following Greenland Government Approval September 2, 2026 9:00 AM - StreetInsider NeoGenomics wins Medicare coverage for cancer immunotherapy test August 26, 2026 4:17 PM - StreetInsider NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring August 26, 2026 4:17 PM - BizWire Form 4 NEOGENOMICS INC For: Aug 21 Filed by: Stone Warren August 25, 2026 4:33 PM - SEC Filing Form S-8 NEOGENOMICS INC August 25, 2026 4:02 PM - SEC Filing Form SCHEDULE 13G/A NEOGENOMICS INC Filed by: First Light Asset Management, LLC August 14, 2026 4:42 PM - SEC Filing Form 8-K NEOGENOMICS INC For: Aug 07 August 11, 2026 4:10 PM - SEC Filing Form 4 NEOGENOMICS INC For: Aug 04 Filed by: Aunan Greg D August 6, 2026 4:03 PM - SEC Filing Form 144 NEOGENOMICS INC Filed by: Aunan Greg D August 4, 2026 4:20 PM - SEC Filing Form 144 NEOGENOMICS INC Filed by: Sherman Jeffrey Scott July 30, 2026 4:05 PM - SEC Filing Form SCHEDULE 13G/A NEOGENOMICS INC Filed by: BlackRock, Inc. July 30, 2026 1:32 PM - SEC Filing Form SCHEDULE 13G NEOGENOMICS INC Filed by: FIRST TRUST PORTFOLIOS LP July 30, 2026 12:14 PM - SEC Filing Neogenomics (NEO) PT Raised to $19 at Needham July 29, 2026 5:34 AM - StreetInsider NeoGenomics (NEO) Tops Q2 EPS by 2c ; Offers Guidance July 28, 2026 4:23 PM - StreetInsider Form 10-Q NEOGENOMICS INC For: Jun 30 July 28, 2026 4:09 PM - SEC Filing Form 8-K NEOGENOMICS INC For: Jul 28 July 28, 2026 4:06 PM - SEC Filing NeoGenomics Reports Second Quarter 2026 Results July 28, 2026 4:05 PM - BizWire TD Cowen reports short interest changes in life science stocks July 27, 2026 12:15 PM - StreetInsider Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing July 24, 2026 8:35 AM - Globe NewsWire Neogenomics (NEO) PT Raised to $16 at Benchmark July 24, 2026 7:32 AM - StreetInsider Full Article List